معرفی
Jamal Lewis, Ph.D., is an Associate Professor in the J. Crayton Pruitt Family Department of Biomedical Engineering at the University of Florida, within the Herbert Wertheim College of Engineering. His Immuno-modulatory Biomaterials Laboratory focuses on developing biomaterial systems to manipulate the immune system for treating autoimmune diseases, allergies, and transplant rejection. His work integrates biomaterials engineering, drug delivery, and immunology.
Education:
- Ph.D. in Biomedical Engineering, University of Florida (2012)
- M.S. in Biomedical Engineering, North Carolina State University (2007)
- B.S. in Chemical Engineering, Florida A&M University (2004)
Research interests include immunoengineering, biomaterials design for controlled immune responses, and drug delivery systems targeting dendritic cells. His lab explores how mechanical forces and biochemical cues influence immune cell behavior, with applications in vaccines and immunotherapies.
Recent publications emphasize biomaterial-based strategies for immunomodulation, including polymeric particle therapies and sustained-release systems. His work spans topics like lactate modulation of immune cells, fungal pathogen interactions, and anti-inflammatory treatments for osteoarthritis.
Notable awards include the University of Florida 40 Under 40 (2021), recognition as a 1000 Inspiring Black Scientist in America (2021), and Biomaterial Science RSC Emerging Investigator (2021). He has contributed to over 50 publications and holds multiple patents related to immunomodulatory materials.
Dr. Lewis leads interdisciplinary collaborations, bridging engineering and immunology. His lab focuses on translating biomaterial innovations into clinical applications for autoimmune diseases and regenerative medicine. Current projects include developing nanoparticle-based vaccines and microfluidic fabrication methods for precision medicine.
